Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 27;88(2):e0007623.
doi: 10.1128/mmbr.00076-23. Epub 2024 May 31.

Genotypic diversity, virulence, and molecular genetic tools in Histoplasma

Affiliations
Review

Genotypic diversity, virulence, and molecular genetic tools in Histoplasma

Victoria E Sepúlveda et al. Microbiol Mol Biol Rev. .

Abstract

SUMMARYHistoplasmosis is arguably the most common fungal respiratory infection worldwide, with hundreds of thousands of new infections occurring annually in the United States alone. The infection can progress in the lung or disseminate to visceral organs and can be difficult to treat with antifungal drugs. Histoplasma, the causative agent of the disease, is a pathogenic fungus that causes life-threatening lung infections and is globally distributed. The fungus has the ability to germinate from conidia into either hyphal (mold) or yeast form, depending on the environmental temperature. This transition also regulates virulence. Histoplasma and histoplasmosis have been classified as being of emergent importance, and in 2022, the World Health Organization included Histoplasma as 1 of the 19 most concerning human fungal pathogens. In this review, we synthesize the current understanding of the ecological niche, evolutionary history, and virulence strategies of Histoplasma. We also describe general patterns of the symptomatology and epidemiology of histoplasmosis. We underscore areas where research is sorely needed and highlight research avenues that have been productive.

Keywords: Histoplasma; mycoses; virulence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Spectrum of histoplasmosis. Left: Histoplasma is found in nitrogen-rich soil, which is usually provided by bird or bat guano. Middle: the spectrum of histoplasmosis ranges from asymptomatic infection to severe disseminated disease. Disease outcome is impacted by multiple factors, including the immune status of the host and the quantity of organisms inhaled. Right: strain background also impacts the type of disease. There are strains that cause cutaneous and subcutaneous bone lesions, and other ones that infect horses and mules and cause chronic ulcerative dermatitis, conjunctivitis, and pulmonary histoplasmosis. Modified from an original figure made by Grant S. Jones (with permission). Created with BioRender.com.
Fig 2
Fig 2
(A) Histoplasma species. Phylogenetic tree using whole genome data shows that Histoplasma is composed of at least five different species [tree modified from reference (228)]. Species names represent the nomenclature proposed by Sepúlveda et al. (228) as well as the nomenclature proposed by Kasuga et al. (227) (in parenthesis). (B) Extracellular proteolytic activity in Histoplasma. Secreted proteolytic activity is visible as transparent clearance halos around fungal colonies only in H. mississippiense (NAm 1) strains. Pictures show a reference strain for each species: WU24 (H. mississippiense), G217B (H. ohiense), 3/11 (H. suramericanum), G186A (H. capsulatum), and H88 (African clade). (C) α-(1, 3)-glucan. Smooth morphology occurs in the absence of α-(1, 3)-glucan in the cell walls. H. ohiense (NAm2) is the only species that shows a smooth colony morphology (pictures on panel B) due to the lack of α-(1, 3)-glucan. (D) Virulence. Differences in virulence among Histoplasma species. Conclusions should be drawn carefully when comparing relative virulence among isolates, and strain-level variation should be considered and evaluated before making species-level conclusions. References shown are as follows: (236, 237, 219).

Similar articles

References

    1. Casadevall A. 2017. Don’t forget the fungi when considering global catastrophic biorisks. Health Secur 15:341–342. doi:10.1089/hs.2017.0048 - DOI - PMC - PubMed
    1. Almeida F, Rodrigues ML, Coelho C. 2019. The still underestimated problem of fungal diseases worldwide. Front Microbiol 10:214. doi:10.3389/fmicb.2019.00214 - DOI - PMC - PubMed
    1. Rodrigues AM, Beale MA, Hagen F, Fisher MC, Terra PPD, de Hoog S, Brilhante RSN, de Aguiar Cordeiro R, de Souza Collares Maia Castelo-Branco D, Rocha MFG, Sidrim JJC, de Camargo ZP. 2020. The global epidemiology of emerging Histoplasma species in recent years. Stud Mycol 97:100095. doi:10.1016/j.simyco.2020.02.001 - DOI - PMC - PubMed
    1. Bongomin F, Gago S, Oladele RO, Denning DW. 2017. Lobal and multi-national prevalence of fungal diseases—estimate precision. J Fungi (Basel) 3:57. doi:10.3390/jof3040057 - DOI - PMC - PubMed
    1. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci Transl Med 4:165rv13. doi:10.1126/scitranslmed.3004404 - DOI - PubMed

LinkOut - more resources